These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 65339)

  • 21. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease.
    Koistinen R; Heikinheimo M; Rutanen EM; Stenman UH; Lee JN; Seppälä M
    Oncodev Biol Med; 1981; 2(3):179-82. PubMed ID: 6272237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunochemical identification of beta1-globulin of the "pregnancy zone" in serum of patients with trophoblastic tumors].
    Tatarinov YS; Mesnyankina NV; Nikoulina DM; Novikova LA; Toloknov BO; Falaleeva DM
    Int J Cancer; 1974 Oct; 14(4):548-54. PubMed ID: 4142469
    [No Abstract]   [Full Text] [Related]  

  • 23. Trophoblast-specific beta1-glycoprotein as a marker for pregnancy and malignancies.
    Tatarinov YS
    Gynecol Obstet Invest; 1978; 9(2-3):65-97. PubMed ID: 216610
    [No Abstract]   [Full Text] [Related]  

  • 24. Pregnancy-specific beta1-glycoprotein: a review.
    Horne CH; Towler CM
    Obstet Gynecol Surv; 1978 Dec; 33(12):761-8. PubMed ID: 84369
    [No Abstract]   [Full Text] [Related]  

  • 25. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ; Buck RH; Joubert SM
    S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 29. [A study on pregnancy-specific beta 1-globulin assay (SP1-RIA) and its diagnostic application (author's transl)].
    Komishi K; Azuma S
    Horumon To Rinsho; 1982 Feb; 30(2):189-95. PubMed ID: 6282504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Assessment of RIA kit for measuring pregnancy-specific beta 1 glycoprotein (SP1) and its clinical significance as a tumor marker (author's transl)].
    Tsujino D; Chida R; Sasaki Y; Someya K; Shibata K
    Radioisotopes; 1981 Sep; 30(9):502-4. PubMed ID: 6276932
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP
    Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta lactoglobulin homologue placental protein 14 (PP14) in serum of patients with trophoblastic disease and non-trophoblastic gynecologic malignancy.
    Than GN; Tatra G; Szabó DG; Csaba IF; Bohn H
    Arch Gynecol Obstet; 1988; 243(3):131-7. PubMed ID: 2844125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-Subunit in sera of choriocarcinoma patients in remission.
    Quigley MM; Tyrey L; Hammond CB
    J Clin Endocrinol Metab; 1980 Jan; 50(1):98-102. PubMed ID: 6243136
    [No Abstract]   [Full Text] [Related]  

  • 37. Major basic protein as a marker of malignant potential in trophoblastic neoplasia.
    Gurian KV; Podratz KC; Elg SA; Twiggs LB; Lurain JR; Wagner JM; Gleich GJ
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):632-7. PubMed ID: 8828426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-2-microglobulin in trophoblastic disease.
    Norman RJ; Jialal I; Joubert SM; Green-Thompson RW
    S Afr Med J; 1983 Jul; 64(3):90-2. PubMed ID: 6191398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.